Yu Chen

7PUBLICATIONS
15CO-AUTHORS
Separation technologiesHaematological tumoursMolecular targetsGene and molecular therapyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 31, 2026
Macropinocytosis-mediated recyclable LYTACs (McR-TACs) for receptor-independent protein degradation.

|Feb 06, 2026
Engineering platelets as cancer therapeutics.

Yu Chen, Tyler Wolter, Zhen Gu

|Aug 19, 2025
Programmable immunoprobiotics orchestrate antitumor immune response with Pin1 inhibition for pancreatic cancer treatment.

Sichen Yuan, Xicheng Yang, Alexa M Bremmer

|May 16, 2025
Engineering pyroptotic vesicles as personalized cancer vaccines.

Zhaoting Li, Yixin Wang, Fanyi Mo

|Dec 03, 2024
Engineered platelets as targeted protein degraders and application to breast cancer models.

Yu Chen, Samira Pal, Wen Li

|Aug 22, 2024
Proteolysis-targeting drug delivery system (ProDDS): integrating targeted protein degradation concepts into formulation design.

Yu Chen, Fengyuan Liu, Samira Pal

Pageof 2

Frequent Collaborators

7 joint publications

Quanyin Hu

3 joint publications

Sichen Yuan

2 joint publications

Fengyuan Liu

2 joint publications

Tyler Wolter